Sunshine Biopharma Inc (SBFM) — Tangible Net Worth Ratio
Sunshine Biopharma Inc (SBFM) has a Tangible Net Worth Ratio of 91.8% as of March 2026. This metric is calculated by deducting intangible assets ($1.89 Million) from net assets ($23.04 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Sunshine Biopharma Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Sunshine Biopharma Inc Tangible Net Worth Ratio (2007–2025)
This chart shows how Sunshine Biopharma Inc's Tangible Net Worth Ratio has changed across 10 annual periods from 2007 to 2025. As of March 2026, the ratio stands at 91.8%, reflecting net assets of $23.04 Million with intangible assets of $1.89 Million USD. See defensive interval ratio of Sunshine Biopharma Inc to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Sunshine Biopharma Inc (2007–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Sunshine Biopharma Inc from 2007 to 2025, covering 10 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see SBFM market cap.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 91.8% | $23.04 Million | $1.89 Million | $30.08 Million | ▲ +4.6 pp |
| 2024 | 87.2% | $23.50 Million | $3.02 Million | $30.56 Million | ▼ -6.0 pp |
| 2023 | 93.2% | $21.21 Million | $1.44 Million | $27.35 Million | ▼ -3.2 pp |
| 2022 | 96.4% | $21.63 Million | $776.86K | $29.55 Million | ▼ -3.6 pp |
| 2021 | 100.0% | $211.66K | $0.00 | $2.20 Million | ▲ +0.0 pp |
| 2012 | 100.0% | $70.43K | $0.00 | $134.79K | ▲ +0.0 pp |
| 2011 | 100.0% | $103.00K | $0.00 | $106.44K | ▲ +0.0 pp |
| 2010 | 100.0% | $196.22K | $0.00 | $207.62K | ▲ +0.0 pp |
| 2009 | 100.0% | $97.80K | $0.00 | $112.12K | ▲ +0.0 pp |
| 2007 | 100.0% | $13.39K | $0.00 | $14.89K | — |